Drug Database
Back to search

Poland· PL-100195390

Extavia

A interferon beta-1b product containing interferonum beta-1b, registered in Poland by Novartis Europharm Limited. The same ATC class is registered in 14 of our 19 countries.

ATC L03AB08

Checked against URPL (Poland) on

Informational only — not a medical device.

SOURCE REGISTER · PLURPL (Poland)normalisedExtaviaATCL03AB08REGISTER NO.PL-100195390PACKS LISTED3CHECKEDSeptember 27, 2026
Compare price across countriesPer daily dose · free accountAsk the assistant about interferonum beta-1bAnswers with sources · free accountCheck interactionsSeverity free · mechanism on Growth

Where it is registered

Interferon beta-1b is registered in 14 of 19 countries.

Countries holding a registration under ATC L03AB08 (interferon beta-1b), each read from that country’s own register.

  • This record: Poland, from URPL (Poland)
  • 9 of them publish a price we can compare per daily dose
Search interferon beta-1b products by name

Interferon beta-1b · ATC L03AB08

14 / 19 countries

  • Belgiumprice
  • Canada
  • Czechiaprice
  • Denmark
  • Finlandprice
  • Franceprice
  • Icelandprice
  • Ireland
  • Netherlands
  • Norwayprice
  • Polandprice
  • Spainprice
  • Switzerlandprice
  • United Kingdom
Blue: a registration under this ATC code. The ringed marker is this record’s country. Markets marked price publish a price we can compare per daily dose.

The record

At a glance

URPL (Poland)
Active substance
Interferonum beta-1b
Manufacturer
Novartis Europharm Limited
Country
Poland (PL)
ATC code
L03AB08
ATC class
Interferon beta-1b
Defined daily dose
4 MIO, E
Reimbursed
Not published by this register
Source register
URPL (Poland)
Last checked
September 27, 2026

Packs & prices · 3

  • gtin
    05909990650989
  • gtin
    05909990687008
  • gtin
    05909990650996

Regulatory notes

No shortage, Orange Book or US label notes for this record.

Interactions

347 interactions on record for interferon beta-1b.

Graded by severity as the source publishes them — 15 severe. Severity grades are free for everyone; mechanism and management come with Growth.

  • Severity for every pair — free, no plan needed
  • The source, licence and sync date on every record
  • Mechanism and what to do for each pair — Growth plan
Check interferon beta-1b against other medicinesHow interaction checks work

Interferon beta-1b · interactions on record

347 records

  • 15 severe
  • 332 moderate

Most severe, free to view

  • MipomersenC10AX11severe
  • LomitapideC10AX12severe
  • ZidovudineJ05AF01severe
  • ClotrimazoleA01AB18moderate
  • Interaction severity from DDInter 2.0 (Xiong G. et al., Nucleic Acids Res.), licensed CC BY-NC 4.0 — free for non-commercial use only; not covered by the Drug Database commercial licence.
Mechanism and what to do, in the interaction check
Source: DDInter 2.0 · synced 29 Sept 2026. Grades as the source publishes them.

Same medicine, other countries

Interferon beta-1b in 15 other countries

What each register calls a product with the same active substance — salts and hydrates count as the same.

All interferon beta-1b products

Authorised across Europe · EMA

The same active substance is authorised in 3 EEA countries. Names it is sold under:

  • Iceland · Betaferon
  • Liechtenstein · Betaferon
  • Norway · Betaferon

Source: European Medicines Agency, Article 57 product data.

Sourced from a public register and reproduced with attribution. Drug Database is not affiliated with, endorsed by, or a partner of URPL (Poland). This is an informational data service and not a medical device — verify against the official source of record before any clinical decision.

For developers

The same record over the API, and the raw payload
GET /v1/drugs/e0296fe2-17a1-4a06-bc8a-60b4089efc77
GET /v1/drugs/e0296fe2-17a1-4a06-bc8a-60b4089efc77?format=fhir

Every response carries last_synced_at, so freshness is a field rather than a promise. Below is exactly what the ingestion wrote, before any presentation — the same JSON the API returns under payload.

{
  "form": "Proszek i rozpuszczalnik do sporządzania roztworu do wstrzykiwań",
  "source": "urpl",
  "strength": "250 mcg/ml",
  "packaging": "Rpz ¦ Skasowane ¦ EU/1/08/454/002 ¦ 29802\n15 fiol.  proszku + 15 amp.-strzyk. rozp.\n05909990650989 ¦ Rpz ¦ Skasowane ¦ EU/1/08/454/001 ¦ 44128\n5 fiol.  proszku + 5 amp.-strzyk. rozp.\n05909990687008 ¦ Rpz ¦ Skasowane ¦ EU/1/08/454/005 ¦ 48761\n45 fiol.  proszku + 45 amp.-strzyk. rozp.\n05909990650996 ¦ Rpz ¦ EU/1/08/454/008 ¦ 81979\n15 fiol. 3 ml proszku ¦ 15 amp.-strzyk. 1,2 ml rozpuszalnik\nRpz ¦ EU/1/08/454/010 ¦ 119797\n5 fiol. 3 ml proszku ¦ 5 amp.-strzyk. 1,2 ml rozpuszczalnik\nRpz ¦ EU/1/08/454/011 ¦ 119798\n14 fiol. 3 ml proszku ¦ 14 amp.-strzyk. 1,2 ml rozpuszczalnik\nRpz ¦ EU/1/08/454/013 ¦ 119799\n14 fiol. 3 ml proszku ¦ 15 amp.-strzyk. 1,2 ml rozpuszczalnik\nRpz ¦ EU/1/08/454/014 ¦ 119800\n42 fiol. 3 ml proszku ¦ 45 amp.-strzyk. 1,2 ml rozpuszczalnik\nRpz ¦ EU/1/08/454/012 ¦ 119801\n42 fiol. 3 ml proszku ¦ 42 amp.-strzyk. 1,2 ml rozpuszczalnik\nRpz ¦ EU/1/08/454/009 ¦ 119802\n45 fiol. 3 ml proszku ¦ 45 amp.-strzyk. 1,2 ml rozpuszczalnik",
  "substance": "Interferonum beta-1b 250 mcg/ml",
  "common_name": "Interferonum beta-1b",
  "pl_product_id": "100195390",
  "pozwolenie_nr": null,
  "auth_procedure": "CEN",
  "authorisation_validity": "2024-11-25"
}
API referenceMCP serverPlans

See everything about interferon beta-1b.

This page is the registration. A free account adds the label text as the regulator wrote it, what it costs per daily dose across the markets that publish a price, a feed of what changes in the registers, and an assistant that answers with its sources. Interaction severity is free; mechanism and management are on the Growth plan. No card, nothing to install.

Try it freeOpen in the console